Daniel M. Forton

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Characterising Hepatitis D Virus in the UK From 2011 to 2021.

Characterising Hepatitis D Virus in the UK From 2011 to 2021.

Journal: Journal of viral hepatitis

Published: March 20, 2026

Emergency Department Opt-Out Testing for Hepatitis B: A Two-Year UK Multicentre Evaluation of Outcomes Across Seven Sites.

Emergency Department Opt-Out Testing for Hepatitis B: A Two-Year UK Multicentre Evaluation of Outcomes Across Seven Sites.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 05, 2026

The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.

The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensus.

Journal: The lancet. Gastroenterology & hepatology

Published: December 21, 2025

Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial).

Nucleos(t)ide withdrawal vs Nucleos(t)ide withdrawal with adjuvant pegylated-interferon in HBeAg-negative hepatitis B virus infection (NUC-B Trial).

Journal: Hepatology (Baltimore, Md.)

Published: September 19, 2025

Utility and cost-effectiveness of LiverMultiScan for MASLD diagnosis: a real-world multi-national randomised clinical trial.

Utility and cost-effectiveness of LiverMultiScan for MASLD diagnosis: a real-world multi-national randomised clinical trial.

Journal: Communications medicine

Published: September 26, 2023

KIR-HLA interactions extend human CD8+ T cell lifespan in vivo.

KIR-HLA interactions extend human CD8+ T cell lifespan in vivo.

Journal: The Journal of clinical investigation

Published: February 06, 2023

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C.

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C.

Journal: Wellcome open research

Published: July 14, 2021

IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Journal: Emerging infectious diseases

Published: December 01, 2020

First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID-19 in an allogeneic stem cell transplant patient.

First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID-19 in an allogeneic stem cell transplant patient.

Journal: EJHaem

Published: October 02, 2020

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial.

Journal: JAMA

Published: September 03, 2020

Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials.

Insights from compassionate use of tocilizumab for COVID-19 to inform appropriate design of randomised controlled trials.

Journal: British journal of clinical pharmacology

Published: May 12, 2020

Differential effect of interferon-alpha treatment on AEA and 2-AG levels.

Differential effect of interferon-alpha treatment on AEA and 2-AG levels.

Journal: Brain, behavior, and immunity

Published: March 03, 2020

Showing 1-12 of 35

Last Updated: 09/26/2026